Postmarketing surveillance for drug safety: surely we can do better

Clin Pharmacol Ther. 2004 Jun;75(6):491-4. doi: 10.1016/j.clpt.2004.01.017.
No abstract available

Publication types

  • Comment
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Antirheumatic Agents / adverse effects
  • Antirheumatic Agents / standards
  • Antirheumatic Agents / therapeutic use
  • Drug Therapy / standards
  • Drug Therapy / trends
  • Drug-Related Side Effects and Adverse Reactions*
  • Humans
  • Product Surveillance, Postmarketing / methods*
  • Product Surveillance, Postmarketing / standards*
  • Product Surveillance, Postmarketing / trends

Substances

  • Antirheumatic Agents